INTEGRA Biosciences cuts Scope 3 emissions and boosts solar power on path to net zero
news-medical.netINTEGRA Biosciences has reported progress on its net zero goals three years after joining the Science Based Targets initiative. The company now generates 970 MWh of solar electricity on site each year and has increased its renewable energy use from 48% to 98% since 2021. It also cut Scope 3 emissions per turnover by 28%, mainly by halving air freight and reducing plastic in pipette tip boxes by 50%. The company is working with the myclimate foundation to track its carbon footprint and has earned gold status in the My Green Lab ACT Ecolabel program for its AUTO racks. These results show a lab equipment manufacturer making measurable cuts in both operational and supply chain emissions. The shift from 48% to 98% renewable energy in five years is a concrete example of what SBTi-aligned action looks like at the company level. The 28% reduction in Scope 3 emissions per turnover is notable because supply chain emissions are often the hardest to move. The article does not give absolute Scope 3 numbers or a baseline year for the per turnover metric, which would help assess the scale of the reduction. Still, the combination of on site solar, air freight cuts, and product material savings shows a multi lever approach that other manufacturers could follow.
